Metaphore Biotechnologies
Derek VanDyke is a professional with experience in leading collaborative projects in biotechnology, pharmaceuticals, and academia. Derek has a background in chemical and biomolecular engineering, with a focus on protein engineering and nanoparticle synthesis for medical applications. Derek has held roles ranging from Research Assistant to Senior Scientist, demonstrating their expertise in cell culture processes and antibody development.
This person is not in any offices
Metaphore Biotechnologies
Metaphore Biotechnologies is harnessing the power of biomimicry and machine learning to unlock the transformative therapeutic potential of functional molecular mimics. The company’s MIMiC™ platform is a computationally driven bioplatform designing new therapeutics where function, specificity, and selectivity can be optimized. Metaphore is focused on making previously intractable drug targets accessible and unlocking breakthroughs that outperform today’s drugs for maximum patient impact. Metaphore was founded in 2021 in Flagship Labs, a unit of Flagship Pioneering.